Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature.
BRAF V600E mutation
Bevacizumab
Epithelioid glioblastoma
Multicentric glioma
TERT promoter mutation
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
12
2019
accepted:
31
12
2019
entrez:
23
1
2020
pubmed:
23
1
2020
medline:
23
1
2020
Statut:
epublish
Résumé
Epithelioid glioblastoma is a rare aggressive variant of glioblastoma multiforme (GBM), which was formally recognized by the World Health Organization classification of the central nervous system in 2016. Clinically, epithelioid GBMs are characterized by aggressive features, such as metastases and cerebrospinal fluid dissemination, and an extremely poor prognosis. A rare case of epithelioid GBM that was discovered as a multicentric glioma with different histopathology is reported. A 78-year-old man was admitted to our hospital with mild motor weakness of the right leg. Neuroimaging showed small masses in the left frontal and parietal lobes on magnetic resonance imaging. The abnormal lesion had been increasing rapidly for 3 weeks, and a new lesion appeared in the frontal lobe. 11C-methionine positron emission tomography (PET) showed abnormal uptake corresponding to the lesion. To reach a definitive diagnosis, surgical excision of the right frontal mass lesion was performed. Histological findings showed diffuse astrocytoma. Only radiotherapy was planned, but the left frontal and parietal tumors progressed further within a short period. Therefore, it was thought that these tumors were GBM, and a biopsy of the left parietal tumor was performed. The histological diagnosis was epithelioid GBM. Immunohistochemistry showed that most tumor cells were negatively stained for p53 and isocitrate dehydrogenase 1. Epithelioid GBM is one of the rarest morphologic subtypes of GBM and has a strongly infiltrative and aggressive nature. Therefore, careful identification of preoperative imaging studies and detailed evaluation of genetic studies are necessary to select the appropriate treatment for epithelioid GBM.
Sections du résumé
BACKGROUND
BACKGROUND
Epithelioid glioblastoma is a rare aggressive variant of glioblastoma multiforme (GBM), which was formally recognized by the World Health Organization classification of the central nervous system in 2016. Clinically, epithelioid GBMs are characterized by aggressive features, such as metastases and cerebrospinal fluid dissemination, and an extremely poor prognosis. A rare case of epithelioid GBM that was discovered as a multicentric glioma with different histopathology is reported.
CASE DESCRIPTION
METHODS
A 78-year-old man was admitted to our hospital with mild motor weakness of the right leg. Neuroimaging showed small masses in the left frontal and parietal lobes on magnetic resonance imaging. The abnormal lesion had been increasing rapidly for 3 weeks, and a new lesion appeared in the frontal lobe. 11C-methionine positron emission tomography (PET) showed abnormal uptake corresponding to the lesion. To reach a definitive diagnosis, surgical excision of the right frontal mass lesion was performed. Histological findings showed diffuse astrocytoma. Only radiotherapy was planned, but the left frontal and parietal tumors progressed further within a short period. Therefore, it was thought that these tumors were GBM, and a biopsy of the left parietal tumor was performed. The histological diagnosis was epithelioid GBM. Immunohistochemistry showed that most tumor cells were negatively stained for p53 and isocitrate dehydrogenase 1.
CONCLUSION
CONCLUSIONS
Epithelioid GBM is one of the rarest morphologic subtypes of GBM and has a strongly infiltrative and aggressive nature. Therefore, careful identification of preoperative imaging studies and detailed evaluation of genetic studies are necessary to select the appropriate treatment for epithelioid GBM.
Identifiants
pubmed: 31966927
doi: 10.25259/SNI_544_2019
pii: SNI-11-8
pmc: PMC6969379
doi:
Types de publication
Case Reports
Langues
eng
Pagination
8Informations de copyright
Copyright: © 2020 Surgical Neurology International.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Neuropathology. 2016 Apr;36(2):181-6
pubmed: 26375727
Brain Pathol. 2018 Sep;28(5):663-673
pubmed: 29105198
Am J Surg Pathol. 2013 May;37(5):685-98
pubmed: 23552385
N Engl J Med. 2014 Feb 20;370(8):699-708
pubmed: 24552317
Br J Neurosurg. 1990;4(6):535-9
pubmed: 1963788
Br J Neurosurg. 1991;5(6):631-4
pubmed: 1772610
N Engl J Med. 2014 Feb 20;370(8):709-22
pubmed: 24552318
Neuropathol Appl Neurobiol. 2014 Apr;40(3):327-36
pubmed: 24127995
Brain Tumor Pathol. 2011 Feb;28(1):65-70
pubmed: 21213124
Am J Surg Pathol. 2010 Mar;34(3):341-54
pubmed: 20118769
BMC Cancer. 2019 May 14;19(1):445
pubmed: 31088401
Oncotarget. 2019 Jun 04;10(38):3818-3826
pubmed: 31217909
J Neurosurg. 1963 Feb;20:122-36
pubmed: 14192080
Neuropathology. 2011 Aug;31(4):421-6
pubmed: 21092062
Acta Neuropathol Commun. 2019 Jul 25;7(1):119
pubmed: 31345255
Brain Pathol. 2018 Sep;28(5):656-662
pubmed: 28990704
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
World J Surg Oncol. 2016 May 26;14(1):152
pubmed: 27230073